Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
According to a new article in the journal Nutrition and Cancer, “Consistent online dietary recommendations are lacking for patients during and after cancer treatment.” This will hardly come as a shock to many in the prostate cancer community, but an article like this one may help to initiate development of better guidelines. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: guidance, guidelines, nutrition | 3 Comments »
According to a report on the Medscape Oncology web site this morning, the National Comprehensive Cancer Network (NCCN) has just released, for the first time, guidelines for clinicians that address factors affecting “survivorship” after a diagnosis of and treatment for cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Uncategorized | Tagged: guidelines, NCCN, survivorship | Leave a Comment »
As fodder for the ongoing discussion about the appropriateness of PSA testing (particularly of younger, healthy men) and risk for prostate cancer, we would draw our reader’s attention to an article from the Annals of Family Medicine just reprinted on the Medscape web site. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guidelines, screening, testing | 2 Comments »
In an article just published in the Journal of Clinical Oncology, the American Society of Clinical Oncology (ASCO) has strongly recommended against the use of advanced imaging technologies for determining the spread of prostate cancer in men with early stage, low-risk disease. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: ASCO, Choosing Wisely, guidelines, outcome | 1 Comment »
Many organizations develop guidelines for the prevention, diagnosis, and treatment of cancer (prostate cancer included). And the differences between these guidelines can be striking and controversial … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention | Tagged: American Cancer Society, guidelines | 2 Comments »
The following article, by Ravinder Mohan, MD, PhD, is reproduced from the UroToday web site with kind permission of Dr. Mohan and the publishers of UroToday. We had previously commented on the original article, published last month in American Family Physician. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: decision-making, guidelines, localized, patient, patient-centered, Treatment | 5 Comments »
A new analysis of data from > 5,500 men who participated in the Prostate Cancer Prevention Trial has directly challenged the recommendation in some clinical guidelines regarding the use of PSA velocity as an indicator for immediate biopsy. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, guidelines, PSA, velocity | Leave a Comment »
A new article in BJU International provides patients with some insight into just how closely members of the urology community tend to follow some of the guidelines issued by their professional organizations with regard to the management of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: adherence, guidelines, urologist | 5 Comments »
At some point in the past 3 weeks or so, the National Comprehensive Cancer Network (NCCN) Foundation has quietly issued its new NCCN Guidelines for Patients™ on prostate cancer diagnosis and management. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, guidelines, Management, NCCN, patient | Leave a Comment »
The National Comprehensive Cancer Network has updated its prostate cancer management guidelines to give a category 1 recommendation for clinical use of sipuleucel-T (Provenge) in the treatment of selected patients. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: guidelines, NCCN, Provenge, sipuleucel-T | Leave a Comment »
In a long media release today, the National Comprehensive Cancer Network (NCCN) encapsulated a presentation at the NCCN’s 15th Annual Conference by Dr. James L. Mohler, in which he discussed the role of active surveillance and other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, guidelines, NCCN, Treatment | Leave a Comment »
The following media release, referring to the new screening and early detection guidelines issued by the American Cancer Society, was distributed earlier today by Prostate Cancer International and other members of America’s Prostate Cancer Organizations: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: early detection, guidelines, screening | 3 Comments »
As of 10:00 am this morning Eastern Standard Time, the American Cancer Society issued the following media release about newly published guidelines on screening for prostate cancer. We have given this press release in full, without further comment at this time. The only addition to the press release is the direct link to the complete, newly-published guidelines. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: American Cancer Society, guidelines, new, screening | 3 Comments »
In a media release issued earlier today, the National Comprehensive Cancer Network (NCCN) has announced updates to the NCCN Clinical Practice Guidelines for Oncology™ for Prostate Cancer, and has placed a new emphasis on the value of active surveillance in management of men with low and very low risk of clinically significant disease. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: active surveillance, guidelines, National Comprehensive Cancer Network, NCCN | 7 Comments »
In today’s news report we note new articles on:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: guidelines, low risk, PSA, rectum, upgrading, upstaging | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site